UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:C20orf112-ASXL1 |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: C20orf112-ASXL1 | FusionPDB ID: 11459 | FusionGDB2.0 ID: 11459 | Hgene | Tgene | Gene symbol | C20orf112 | ASXL1 | Gene ID | 140688 | 171023 |
Gene name | nucleolar protein 4 like | ASXL transcriptional regulator 1 | |
Synonyms | C20orf112|C20orf113 | BOPS|MDS | |
Cytomap | 20q11.21 | 20q11.21 | |
Type of gene | protein-coding | protein-coding | |
Description | nucleolar protein 4-like | polycomb group protein ASXL1additional sex combs like 1, transcriptional regulatoradditional sex combs like transcriptional regulator 1putative Polycomb group protein ASXL1 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | Q8IXJ9 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000475781, ENST00000326071, ENST00000359676, ENST00000375677, ENST00000375678, ENST00000201961, | ENST00000306058, ENST00000375687, ENST00000375689, ENST00000470145, ENST00000542461, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 4 X 7 X 4=112 | 10 X 7 X 6=420 |
# samples | 5 | 10 | |
** MAII score | log2(5/112*10)=-1.16349873228288 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(10/420*10)=-2.0703893278914 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: C20orf112 [Title/Abstract] AND ASXL1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | C20orf112(31062404)-ASXL1(30954187), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | C20orf112-ASXL1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. C20orf112-ASXL1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. C20orf112-ASXL1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. C20orf112-ASXL1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. C20orf112-ASXL1 seems lost the major protein functional domain in Tgene partner, which is a CGC due to the frame-shifted ORF. C20orf112-ASXL1 seems lost the major protein functional domain in Tgene partner, which is a epigenetic factor due to the frame-shifted ORF. C20orf112-ASXL1 seems lost the major protein functional domain in Tgene partner, which is a tumor suppressor due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | ASXL1 | GO:0035522 | monoubiquitinated histone H2A deubiquitination | 20436459 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | Non-Cancer | ERR315395 | C20orf112 | chr20 | 31062404 | - | ASXL1 | chr20 | 30954187 | + |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000359676 | C20orf112 | chr20 | 31062404 | - | ENST00000470145 | ASXL1 | chr20 | 30954187 | + | 1325 | 252 | 41 | 412 | 123 |
ENST00000326071 | C20orf112 | chr20 | 31062404 | - | ENST00000470145 | ASXL1 | chr20 | 30954187 | + | 1436 | 363 | 152 | 523 | 123 |
ENST00000375677 | C20orf112 | chr20 | 31062404 | - | ENST00000470145 | ASXL1 | chr20 | 30954187 | + | 1276 | 203 | 19 | 363 | 114 |
ENST00000375678 | C20orf112 | chr20 | 31062404 | - | ENST00000470145 | ASXL1 | chr20 | 30954187 | + | 2760 | 1687 | 1179 | 1847 | 222 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000359676 | ENST00000470145 | C20orf112 | chr20 | 31062404 | - | ASXL1 | chr20 | 30954187 | + | 0.044436008 | 0.955564 |
ENST00000326071 | ENST00000470145 | C20orf112 | chr20 | 31062404 | - | ASXL1 | chr20 | 30954187 | + | 0.09484311 | 0.90515685 |
ENST00000375677 | ENST00000470145 | C20orf112 | chr20 | 31062404 | - | ASXL1 | chr20 | 30954187 | + | 0.13798022 | 0.86201984 |
ENST00000375678 | ENST00000470145 | C20orf112 | chr20 | 31062404 | - | ASXL1 | chr20 | 30954187 | + | 0.01540936 | 0.98459065 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >11459_11459_1_C20orf112-ASXL1_C20orf112_chr20_31062404_ENST00000326071_ASXL1_chr20_30954187_ENST00000470145_length(amino acids)=123AA_BP=70 MSPPPAPLTRGSRPPISASLPAQDETSVSSEDFDMSDSTWMSADPHLASSLSPSQDERMRSPQNLHSQEDGIRKLLGCSNDTKTDSAGHR -------------------------------------------------------------- >11459_11459_2_C20orf112-ASXL1_C20orf112_chr20_31062404_ENST00000359676_ASXL1_chr20_30954187_ENST00000470145_length(amino acids)=123AA_BP=70 MSPPPAPLTRGSRPPISASLPAQDETSVSSEDFDMSDSTWMSADPHLASSLSPSQDERMRSPQNLHSQEDGIRKLLGCSNDTKTDSAGHR -------------------------------------------------------------- >11459_11459_3_C20orf112-ASXL1_C20orf112_chr20_31062404_ENST00000375677_ASXL1_chr20_30954187_ENST00000470145_length(amino acids)=114AA_BP=61 MKQMKLRVMNSQEQDETSVSSEDFDMSDSTWMSADPHLASSLSPSQDERMRSPQNLHSQEDGIRKLLGCSNDTKTDSAGHRGRRTKGNEK -------------------------------------------------------------- >11459_11459_4_C20orf112-ASXL1_C20orf112_chr20_31062404_ENST00000375678_ASXL1_chr20_30954187_ENST00000470145_length(amino acids)=222AA_BP=169 MSEPEGISLKRVAVVEDFFDIIYSMHVESSAEPGKAPKHAGQKKTYRAIAETYAFLPREAVTRFLMSCTECQKRMHFNSNGLEPKENEPP SPLVSGIIDYNMPLTSTYLKQMKLRVMNSQEQDETSVSSEDFDMSDSTWMSADPHLASSLSPSQDERMRSPQNLHSQEDGIRKLLGCSND -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr20:31062404/chr20:30954187) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | ASXL1 |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Probable Polycomb group (PcG) protein involved in transcriptional regulation mediated by ligand-bound nuclear hormone receptors, such as retinoic acid receptors (RARs) and peroxisome proliferator-activated receptor gamma (PPARG) (PubMed:16606617). Acts as coactivator of RARA and RXRA through association with NCOA1 (PubMed:16606617). Acts as corepressor for PPARG and suppresses its adipocyte differentiation-inducing activity (By similarity). Non-catalytic component of the PR-DUB complex, a complex that specifically mediates deubiquitination of histone H2A monoubiquitinated at 'Lys-119' (H2AK119ub1) (PubMed:20436459). Acts as a sensor of N(6)-methyladenosine methylation on DNA (m6A): recognizes and binds m6A DNA, leading to its ubiquitination and degradation by TRIP12, thereby inactivating the PR-DUB complex and regulating Polycomb silencing (PubMed:30982744). {ECO:0000250|UniProtKB:P59598, ECO:0000269|PubMed:16606617, ECO:0000269|PubMed:20436459, ECO:0000269|PubMed:30982744}. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | ASXL1 | chr20:31062404 | chr20:30954187 | ENST00000375687 | 0 | 13 | 1457_1460 | 19.0 | 1542.0 | Compositional bias | Note=Poly-Ser | |
Tgene | ASXL1 | chr20:31062404 | chr20:30954187 | ENST00000375687 | 0 | 13 | 199_209 | 19.0 | 1542.0 | Compositional bias | Note=Poly-Ser | |
Tgene | ASXL1 | chr20:31062404 | chr20:30954187 | ENST00000375687 | 0 | 13 | 641_684 | 19.0 | 1542.0 | Compositional bias | Note=Gly-rich | |
Tgene | ASXL1 | chr20:31062404 | chr20:30954187 | ENST00000375687 | 0 | 13 | 255_364 | 19.0 | 1542.0 | Domain | DEUBAD | |
Tgene | ASXL1 | chr20:31062404 | chr20:30954187 | ENST00000375687 | 0 | 13 | 160_164 | 19.0 | 1542.0 | Motif | Nuclear localization signal 1 | |
Tgene | ASXL1 | chr20:31062404 | chr20:30954187 | ENST00000375687 | 0 | 13 | 284_288 | 19.0 | 1542.0 | Motif | Note=LXXLL motif | |
Tgene | ASXL1 | chr20:31062404 | chr20:30954187 | ENST00000375687 | 0 | 13 | 409_413 | 19.0 | 1542.0 | Motif | Nuclear localization signal 2 | |
Tgene | ASXL1 | chr20:31062404 | chr20:30954187 | ENST00000375687 | 0 | 13 | 1503_1540 | 19.0 | 1542.0 | Zinc finger | Note=PHD-type%3B atypical |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | C20orf112 | chr20:31062404 | chr20:30954187 | ENST00000359676 | - | 2 | 8 | 161_169 | 36.333333333333336 | 437.0 | Compositional bias | Note=Poly-Asp |
Tgene | ASXL1 | chr20:31062404 | chr20:30954187 | ENST00000375687 | 0 | 13 | 2_9 | 19.0 | 1542.0 | Compositional bias | Note=Poly-Lys | |
Tgene | ASXL1 | chr20:31062404 | chr20:30954187 | ENST00000375687 | 0 | 13 | 11_86 | 19.0 | 1542.0 | Domain | HTH HARE-type |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
![]() |
Gene | STRING network |
C20orf112 | |
ASXL1 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to C20orf112-ASXL1 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to C20orf112-ASXL1 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |